DE69530552T2 - Polymere Antitumormittel - Google Patents

Polymere Antitumormittel

Info

Publication number
DE69530552T2
DE69530552T2 DE69530552T DE69530552T DE69530552T2 DE 69530552 T2 DE69530552 T2 DE 69530552T2 DE 69530552 T DE69530552 T DE 69530552T DE 69530552 T DE69530552 T DE 69530552T DE 69530552 T2 DE69530552 T2 DE 69530552T2
Authority
DE
Germany
Prior art keywords
tumor agents
polymeric anti
agents
polymeric
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69530552T
Other languages
English (en)
Other versions
DE69530552D1 (de
Inventor
Hwei-Ru Tsou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Wyeth LLC
Original Assignee
Wyeth Holdings LLC
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Holdings LLC, Wyeth LLC filed Critical Wyeth Holdings LLC
Application granted granted Critical
Publication of DE69530552D1 publication Critical patent/DE69530552D1/de
Publication of DE69530552T2 publication Critical patent/DE69530552T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/028—Polyamidoamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0273—Polyamines containing heterocyclic moieties in the main chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DE69530552T 1994-11-01 1995-10-26 Polymere Antitumormittel Expired - Fee Related DE69530552T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33266194A 1994-11-01 1994-11-01
US08/521,505 US5609867A (en) 1994-11-01 1995-08-29 Polymeric antitumor agents

Publications (2)

Publication Number Publication Date
DE69530552D1 DE69530552D1 (de) 2003-06-05
DE69530552T2 true DE69530552T2 (de) 2003-11-20

Family

ID=26988319

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69530552T Expired - Fee Related DE69530552T2 (de) 1994-11-01 1995-10-26 Polymere Antitumormittel

Country Status (11)

Country Link
US (1) US5609867A (de)
EP (1) EP0710689B1 (de)
JP (1) JPH08253420A (de)
AT (1) ATE239047T1 (de)
AU (1) AU690740B2 (de)
CA (1) CA2161603A1 (de)
DE (1) DE69530552T2 (de)
DK (1) DK0710689T3 (de)
ES (1) ES2197183T3 (de)
PT (1) PT710689E (de)
TW (1) TW383318B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69708461T2 (de) * 1996-02-15 2002-06-27 Paul J Santerre Bioresponsive pharmakologisch aktive polymere und daraus hergestellte gegenstände
EP3024457A4 (de) 2013-07-26 2017-06-28 Update Pharma Inc. Zusammensetzungen zur verbesserung des therapeutischen nutzens von bisantren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714993A (en) 1970-11-23 1973-02-06 Hughes Tool Co Valving tube subassembly for percussion bit
US4197249A (en) 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4526788A (en) * 1983-03-18 1985-07-02 American Cyanamid Company Polymeric[[(oxazolidinyl)alkyl]amino]anthraquinones
US4520162A (en) * 1983-09-24 1985-05-28 Director-General Of The Agency Of Industrial Science & Technology Polymeric compounds with sustained anti-tumor activity and a method for the preparation thereof
GB8413464D0 (en) 1984-05-25 1984-07-04 Erba Farmitalia Anthracycline-anionic polymer conjugates
DE3768419D1 (de) * 1986-10-07 1991-04-11 Boehringer Biochemia Srl Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
US5378456A (en) * 1993-03-25 1995-01-03 American Cyanamid Company Antitumor mitoxantrone polymeric compositions

Also Published As

Publication number Publication date
EP0710689A2 (de) 1996-05-08
EP0710689B1 (de) 2003-05-02
US5609867A (en) 1997-03-11
ES2197183T3 (es) 2004-01-01
AU690740B2 (en) 1998-04-30
DK0710689T3 (da) 2003-08-04
EP0710689A3 (de) 1996-11-20
PT710689E (pt) 2003-08-29
AU3454795A (en) 1996-05-09
CA2161603A1 (en) 1996-05-02
DE69530552D1 (de) 2003-06-05
JPH08253420A (ja) 1996-10-01
TW383318B (en) 2000-03-01
ATE239047T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
PT639577E (pt) Eteres fosfono-oximetilicos ou metiltiometilicos de derivados do taxano como agentes anti-tumor
DE3865817D1 (de)
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
NZ225339A (en) Compounds having biocidal properties and pharmaceutical compositions
EP1760067A3 (de) Verbindungen mit geschützten Hydroxylgruppen
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
IN170909B (de)
EP0351865A3 (en) Dc-89 compounds and process for their preparation
DE69711996T2 (de) 2-Aminobenzazepin-Derivate und ihre Verwendung für die Behandlung von Immunosuppression
ATE149498T1 (de) Radicicol-derivate, ihre herstellung und ihre antitumorwirkung
DE69530552T2 (de) Polymere Antitumormittel
EP0237829A3 (en) Tetrahydro-3,4-furandiamine-n-n'-platinum complexes
EP1073447A4 (de) N1 modifizierte glycopeptide
DK0688212T3 (da) C9-taxanderivater og farmaceutiske præparater indeholdende disse
EP0297594A3 (de) 3',4'-Di-N-substituierte Epipodophyllotoxin-Glucosid-Derivate
NO905468L (no) Pesticidblandinger.
WO2000000469A3 (en) Alkyl ketones as potent anti-cancer agents
DE3767728D1 (en) Hydroxylierte 1,2-diamincyclohexan platinkomplexe.
TW221051B (de)
EP1011329A4 (de) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
IL161920A0 (en) Photochromic oxazine compounds and methods for their manufacture
IL141655A0 (en) A process for the preparation of midodrine
DE60003560D1 (de) 1,2-dihydro-1-oxo-pyrazino[1,2-]indolederivate
ES8703454A1 (es) Un procedimiento para la preparacion de piridozinilimidazolinonas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee